Replies to post #223170 on Biotech Values

[dewophile]

RVNC

I thought a buyout could be a possibility at this juncture so the raise is slightly disappointing. that said retaining rights to all major geographies and indications increases the opportunity for a wholesale buyout down the road IMO

[jbog]

While that could work out it's potentially a nightmare scenario. Much rather see an appropriate partnership.

If Partnering was on the horizon I wouldn't have thought they'd do this raise. Their initial payment from a partner would be high considering most of the risk has been covered at this point. It's rare when a pharma partners after the ph 3's have shown superiority.

[Cmed123]

If Revance launches alone be prepared for the
post launch short attack... probably good for single
Digit stock price